VANCOUVER, BC — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, reported financial results for the third quarter ended September 30, 2023 and provided a corporate update. Mr. Ian Mortimer, Xenon’s… Read More
WELL expects to announce record quarterly revenue in Q3-2023, underpinned by record care metrics which includes record patient visits¹ of over 1.03 million and almost 1.58 million Total Care Interactions³, which… Read More
VANCOUVER, BC — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including… Read More
TORONTO, ON — LifeLabs is pleased to announce its partnership with LifestyleRx to offer Canadians greater support in managing their health with prediabetes and Type 2 diabetes. Canada has a growing… Read More
VANCOUVER, BC — Renaissance BioScience Corp., a leader in bioengineering for the global food industry, is pleased to announce that it has recently been granted patents for its non-GMO acrylamide-reducing… Read More
